# Crisantaspase for I.M. Injection 10000 (アーウィナーゼ筋注用１００００)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291464E1027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291464E1027
- **Product name (Japanese):** アーウィナーゼ筋注用１００００
- **English title:** Crisantaspase for I.M. Injection 10000
- **Active ingredient:** クリサンタスパーゼ
- **Active ingredient (INN):** Crisantaspase
- **Strength / unit:** １０，０００単位１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Ohara Pharmaceutical (大原薬品工業)
- **NHI price (reference only):** JPY 172931 per １０，０００単位１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291464E1027
- **JSON:** https://www.nifujipharma.com/api/drugs/4291464E1027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Crisantaspase%20for%20I.M.%20Injection%2010000%20(%E3%82%A2%E3%83%BC%E3%82%A6%E3%82%A3%E3%83%8A%E3%83%BC%E3%82%BC%E7%AD%8B%E6%B3%A8%E7%94%A8%EF%BC%91%EF%BC%90%EF%BC%90%EF%BC%90%EF%BC%90)%20%2F%20YJ%204291464E1027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.